Literature DB >> 3531243

Pulmonary megakaryocytes: "missing link" between cardiovascular and respiratory disease?

G K Sharma, I C Talbot.   

Abstract

Pulmonary megakaryocytes were quantitated in a series of 30 consecutive hospital necropsies using a two stage immunoperoxidase stain for factor VIII related antigen. In all 30 cases they were found with a mean density of 14.65 megakaryocytes/cm2 in lung sections of 5 micron in thickness. The maximum concentration of intrapulmonary megakaryocytes was consistently found to be in the central zone of the right upper lobe. Less than 22% of the observed cells possessed abundant cytoplasm, the rest appearing as effete, naked, and seminaked nuclei. The mean megakaryocyte count was found to be increased in association with both respiratory pathology (positive smoking history and impaired lung function) and cardiovascular disease states--shock; thromboembolism; myocardial infarction; and severe atheroma in the abdominal aorta, the coronary circulation, and the circle of Willis. Pulmonary megakaryocytes probably embolise from bone marrow. This may reflect stimulated thrombopoiesis, caused by increased platelet consumption in association with atherosclerotic disease, but it cannot be taken to confirm that the lung is the principal site of platelet production.

Entities:  

Mesh:

Year:  1986        PMID: 3531243      PMCID: PMC500195          DOI: 10.1136/jcp.39.9.969

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  47 in total

1.  Deaths from coronary artery disease and coalworkers' pneumoconiosis.

Authors:  D Davies
Journal:  Br Med J       Date:  1976-10-16

2.  The pulmonary vessels as a filter for circulating megakaryocytes in rats.

Authors:  N T Pedersen
Journal:  Scand J Haematol       Date:  1974

3.  An electron microscope study of the megacaryocyte of the rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat.

Authors:  O Behnke
Journal:  J Ultrastruct Res       Date:  1968-09

4.  Report of Committee on Grading Lesions, Council on Arteriosclerosis, American Heart Association. Grading human atherosclerotic lesions using a panel of photographs.

Authors:  H C McGill; B W Brown; I Gore; G C McMillan; J C Paterson; O J Pollak; J C Roberts; R W Wissler
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

5.  Megakaryocytes in the lung after thrombin initiated diffuse microthrombosis: a preliminary report on ultrastructure.

Authors:  D B Warheit; M I Barnhart
Journal:  Scan Electron Microsc       Date:  1979

6.  Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release.

Authors:  M A Lichtman; J K Chamberlain; W Simon; P A Santillo
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

7.  Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation.

Authors:  E A Trowbridge; J F Martin; D N Slater
Journal:  Thromb Res       Date:  1982-11-15       Impact factor: 3.944

8.  High mean platelet volume after myocardial infarction: is it due to consumption of small platelets?

Authors:  R Sewell; R M Ibbotson; R Phillips; P Carson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

Review 9.  Adult respiratory distress syndrome--a review.

Authors:  P S Hasleton
Journal:  Histopathology       Date:  1983-05       Impact factor: 5.087

10.  Circulating megakaryocytes in patients with pulmonary inflammation and in patients subjected to cholecystectomy.

Authors:  M Hansen; N T Pedersen
Journal:  Scand J Haematol       Date:  1979-09
View more
  10 in total

1.  Lung megakaryocytes display distinct transcriptional and phenotypic properties.

Authors:  Anthony K Yeung; Carlos Villacorta-Martin; Stephanie Hon; Jason R Rock; George J Murphy
Journal:  Blood Adv       Date:  2020-12-22

2.  Link between pulmonary megakaryocytes and cardiovascular and respiratory disease.

Authors:  A Trowbridge; D Slater; J Martin
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

3.  Lung megakaryocytes are immune modulatory cells.

Authors:  Daphne N Pariser; Zachary T Hilt; Sara K Ture; Sara K Blick-Nitko; Mark R Looney; Simon J Cleary; Estheany Roman-Pagan; Jerry Saunders; Steve N Georas; Janelle Veazey; Ferralita Madere; Laura Tesoro Santos; Allison Arne; Nguyen Pt Huynh; Alison C Livada; Selena M Guerrero-Martin; Claire Lyons; Kelly A Metcalf-Pate; Kathleen E McGrath; James Palis; Craig N Morrell
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 4.  Platelet Biogenesis in the Lung Circulation.

Authors:  Emma Lefrançais; Mark R Looney
Journal:  Physiology (Bethesda)       Date:  2019-11-01

5.  Increased numbers of pulmonary megakaryocytes in patients with arterial pulmonary tumour embolism and with lung metastases seen at necropsy.

Authors:  F A Soares
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

6.  SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.

Authors:  Antonio Tombolini; Roberto Scendoni
Journal:  Int J Legal Med       Date:  2020-06-29       Impact factor: 2.686

Review 7.  Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis.

Authors:  Jecko Thachil; Ton Lisman
Journal:  Semin Thromb Hemost       Date:  2020-09-03       Impact factor: 4.180

8.  Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions.

Authors:  Eman Khatib-Massalha; Simón Méndez-Ferrer
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

9.  Ischemic Stroke: An Underestimated Complication of COVID-19.

Authors:  Wen Cao; Cong Zhang; Huan Wang; Qianqian Wu; Yujia Yuan; Junmin Chen; Shuo Geng; Xiangjian Zhang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

Review 10.  COVID-19 update: Covid-19-associated coagulopathy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.